ACCO Brands Corporation stock shows potential despite challenges. Cost-cutting, debt reduction, and buybacks position it for future gains. Learn more on ACCO stock here.

One of the most significant news items involving Vertex isn't reflected in the company's numbers just yet. Vertex's non-opioid pain relief drug, Journavx, received FDA approval on Jan. 30. The drug is ...

McKesson MCK delivered an 18% increase in revenues ($95.3 billion) and a 16% rise in adjusted operating profit during the ...

Coca-Cola posted better-than-expected revenue and profit in the fourth quarter, boosted by higher prices and sales. The beverage giant on Tuesday reported a profit of $2.20 billion, or 51 cents a ...

Coca-Cola reported better-than-expected fourth-quarter results Tuesday, sending shares of the world's biggest soft drink ...

REVENUE FORECAST: Net revenue before exceptional items and amortization--the company's preferred metric--is forecast to fall to 29.96 billion euros ($30.88 billion) in 2024 compared with 30.31 billion ...

Stock Market LIVE Updates | Indian equity indices declined for the fifth consecutive session on Tuesday, weighed down by ...

Today, Benzinga's options scanner spotted 9 options trades for AstraZeneca. This isn't normal. The overall sentiment of these ...

McDonald’s stock rose 5% as investors latched on to the positive developments, despite some mixed results from the fast-food ...

Intelligent Bio Solutions Inc. (Nasdaq: INBS) ("INBS" or the "Company"), a medical technology company delivering intelligent, rapid, non-invasive testing solutions ...

Okomu Oil Palm Plc has reported a pre-tax profit of N52.05 billion for the 2024 financial year, according to its ...

Bullish technicals but overvalued P/B ratio suggests caution; hold for now, consider profit-taking for early investors.